Search TriLink BioTechnologies Products
TriLink BioTechnologies Products
TriLink BioTechnologies, part of Maravai LifeSciences, is a best-in-class contract development and manufacturing organization (CDMO) for synthesis of nucleic acids, NTPs and mRNA capping analogs. TriLink has scale-up expertise and unique production capabilities of mRNA, oligonucleotide & plasmid for companies focused on therapeutic, vaccine, diagnostic and biopharmaceutical breakthroughs. TriLink’s proprietary CleanCap® mRNA co-transcriptional capping technology simplifies mRNA manufacturing by removing additional enzymatic steps, resulting in high capping efficiency and improved yields over traditional co-transcriptional capping methods.
TriLink’s CDMO services offer a range of manufacturing grade products from discovery-grade (RUO) to its customizable intermediate-grade - GMPLink™ to full GMP-grade with scale-up and technology transfer expertise. TriLink operates a quality system in compliance with ICH Q7, Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, Section 19, APIs for Use in Clinical Trials, and ISO 9001:2015 standards.
TriLink continues to expand its cGMP and general mRNA, oligonucleotide & plasmid manufacturing capacity at its new global headquarters to support therapeutic, vaccine and diagnostic customers.
Specialty Oligonucleotides and Nucleoside Triphosphates
- Milligram to multigram capacity
- Affordable, no-obligation oligo production following the FDA’s Quality System Regulations (QSR)
- Industry-leading expertise and technical support
- World-class proficiency in making highly- modified oligonucleotides
- Oligonucleotide radiolabeling services
Still Need More Help?
If you have sales questions relative to particular products or to your line of research,
please contact the CEDARLANE® sales department and have all of your questions answered
in a timely and professional manner.